CA2652214C - Bend-capable tubular prosthesis - Google Patents
Bend-capable tubular prosthesis Download PDFInfo
- Publication number
- CA2652214C CA2652214C CA2652214A CA2652214A CA2652214C CA 2652214 C CA2652214 C CA 2652214C CA 2652214 A CA2652214 A CA 2652214A CA 2652214 A CA2652214 A CA 2652214A CA 2652214 C CA2652214 C CA 2652214C
- Authority
- CA
- Canada
- Prior art keywords
- turn
- struts
- prosthesis
- tubular prosthesis
- stagger
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000001747 exhibiting effect Effects 0.000 claims abstract 2
- 239000000463 material Substances 0.000 claims description 29
- 229910001285 shape-memory alloy Inorganic materials 0.000 claims description 9
- 229910001000 nickel titanium Inorganic materials 0.000 claims description 8
- HZEWFHLRYVTOIW-UHFFFAOYSA-N [Ti].[Ni] Chemical compound [Ti].[Ni] HZEWFHLRYVTOIW-UHFFFAOYSA-N 0.000 claims description 6
- 238000006073 displacement reaction Methods 0.000 claims description 5
- 230000004323 axial length Effects 0.000 claims 2
- 239000011159 matrix material Substances 0.000 description 15
- 238000005452 bending Methods 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 7
- 238000010276 construction Methods 0.000 description 6
- 230000008901 benefit Effects 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 238000009826 distribution Methods 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 230000002159 abnormal effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 241000234295 Musa Species 0.000 description 2
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 230000002411 adverse Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000003698 laser cutting Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/89—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements comprising two or more adjacent rings flexibly connected by separate members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91508—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other the meander having a difference in amplitude along the band
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91516—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other the meander having a change in frequency along the band
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91525—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other within the whole structure different bands showing different meander characteristics, e.g. frequency or amplitude
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91533—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91558—Adjacent bands being connected to each other connected peak to peak
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0028—Shapes in the form of latin or greek characters
- A61F2230/0054—V-shaped
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0069—Three-dimensional shapes cylindrical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0029—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in bending or flexure capacity
Abstract
Stent exhibiting a succession of turns around the axis, adjacent turns being connected by connector portions distributed around the circumference of the prosthesis, each of the turns being made up of struts that extend the length of the turn and are interspersed by inflection zones located at the axial ends of each of the turns. When the prosthesis expands radially, gaps open up between adjacent struts of each of the turns, the inflection zones being distributed regularly around the circumference so that the gaps are substantially the same size as each other around the circumference of the turn, characterised in that at least every second turn exhibits a stagger zone within which the said gap between adjacent said struts is of an individual size different from that common to the other gaps of that second turn.
Description
Bend-capable tubular prosthesis Technical field This invention relates to tubular medical prostheses that are expandable from a radially compact disposition to a radially expanded disposition. In the compact disposition, the prosthesis can by delivered to its operational site in the body, typically trans-luminally and percutaneously, using a delivery system which is a sort of catheter. Exemplary of this class of prosthesis is a nickel titanium shape memory alloy stent for a bodily lumen which is often but not always an arterial lumen. See for example the disclosure of applicant's earlier WO 01/32102.
Background Bodily soft tissue is remarkably flexible and needs generally to be flexible. It is difficult for a metal stent to match bodily tissue for flexibility. WO 01/32102 is concerned with flexibility of the stent during its journey, from outside the body to the operational site within the body, as for example the catheter delivery system advances along a tortuous path from the point of entry in the body. However, there is also a need for metal stents (and other prostheses) that are destined to be installed at a location in the body where severe bending is to be expected. If the prosthesis could be made more tolerant of severe bending after placement, that would be attractive to doctors and their patients.
Background Bodily soft tissue is remarkably flexible and needs generally to be flexible. It is difficult for a metal stent to match bodily tissue for flexibility. WO 01/32102 is concerned with flexibility of the stent during its journey, from outside the body to the operational site within the body, as for example the catheter delivery system advances along a tortuous path from the point of entry in the body. However, there is also a need for metal stents (and other prostheses) that are destined to be installed at a location in the body where severe bending is to be expected. If the prosthesis could be made more tolerant of severe bending after placement, that would be attractive to doctors and their patients.
2 shows what could be termed a "classic" self-expanding stent structure of zig-zag stenting rings composed of struts interspersed by points of inflection and with adjacent stenting rings linked axially by connector portions.
In the compact delivery disposition of the stent (Fig. 3 of WO 01/32102) the struts of the zig-zag rings are more or less parallel to each other so that each point of inflection represents a change of direction for the material of the stenting ring of more or less 180 . As the stent expands to its deployed configuration (Fig. 4 of WO 01/32102) the radius of the stenting ring expands by movement of the struts away from each other so that gaps open up between adjacent struts, and the adjacent points of inflection move further apart (but nevertheless remain spaced at equal intervals to each other around the circumference of the stenting ring).
The connectors serve to restrain relative circumferential movement of the zig-zag rings relative to each other. Thus, if the points of inflection of adjacent stenting rings are facing each other in the compact delivery disposition of the stent, as in WO 01/32102, then so will be these points of inflection still facing each other in the expanded disposition of the stent. When an expanded stent is subject, in the body, to extreme bending, so that the longitudinal axis of the stent is no longer a straight line but a pronounced curve (as in a banana), then the facing points of inflection on the inside of the bend approach each other. The more extreme the bending, the closer the facing points of inflection become until, in the end, these facing "peaks"
abut each other or rub past each other.
Any such abutment or rubbing is undesirable. One way to guard against it is to choose a stent design that can be classified as a "peak-to-valley" design rather than a "peak-to-peak"
design as seen in applicant's WO 01/32102. The art is replete with suggestions for peak-to-valley designs in which the peaks of any one zig-zag stenting ring do not face corresponding peaks of the next adjacent stenting ring but, instead, are circumferentially offset to the peaks of the next adjacent stenting ring by half of the gap between two
In the compact delivery disposition of the stent (Fig. 3 of WO 01/32102) the struts of the zig-zag rings are more or less parallel to each other so that each point of inflection represents a change of direction for the material of the stenting ring of more or less 180 . As the stent expands to its deployed configuration (Fig. 4 of WO 01/32102) the radius of the stenting ring expands by movement of the struts away from each other so that gaps open up between adjacent struts, and the adjacent points of inflection move further apart (but nevertheless remain spaced at equal intervals to each other around the circumference of the stenting ring).
The connectors serve to restrain relative circumferential movement of the zig-zag rings relative to each other. Thus, if the points of inflection of adjacent stenting rings are facing each other in the compact delivery disposition of the stent, as in WO 01/32102, then so will be these points of inflection still facing each other in the expanded disposition of the stent. When an expanded stent is subject, in the body, to extreme bending, so that the longitudinal axis of the stent is no longer a straight line but a pronounced curve (as in a banana), then the facing points of inflection on the inside of the bend approach each other. The more extreme the bending, the closer the facing points of inflection become until, in the end, these facing "peaks"
abut each other or rub past each other.
Any such abutment or rubbing is undesirable. One way to guard against it is to choose a stent design that can be classified as a "peak-to-valley" design rather than a "peak-to-peak"
design as seen in applicant's WO 01/32102. The art is replete with suggestions for peak-to-valley designs in which the peaks of any one zig-zag stenting ring do not face corresponding peaks of the next adjacent stenting ring but, instead, are circumferentially offset to the peaks of the next adjacent stenting ring by half of the gap between two
3 adjacent peaks of the same ring, in the expanded disposition of the stent. Then, under extreme bending, any particular peak on the inside of the bend can advance into the V-shaped space between two peaks of the next adjacent stenting ring, without any abutment or rubbing on any portion of the material of the next adjacent stenting ring.
The present invention is concerned with the above-explained problem. It seeks to improve the in situ bend capability of stents including those seen in WO 01/32102. However, the invention also seeks to achieve this performance enhancement without sacrificing other attractive qualities of stents such as disclosed in WO 01/32102. For example, simplicity of modelling of stress distributions within the stent is attractive in the management of fatigue performance of metal stents. Manufacturing simplicity of course facilitates management of cost which should improve access to stents, for those people who need them.
Looking at WO 01/32102, one can quickly see that performance in extreme bending could be enhanced by extending the length of the portions that connect adjacent zig-zag stenting rings.
The longer these "bridges" then the more the stent can bend without abutment of peaks on the inside of the bend. However, large axial gaps between adjacent stenting rings are not desirable, for then the tissue of the lumen that is being stented by the prosthesis is relatively unsupported, at least between adjacent stenting rings.
For the same reason, one seeks as far as possible to distribute the metallic material of the stent as evenly as possible over the length and circumference of the tubular envelope of the stent so that support for the stented tissue is as even and uninterrupted as possible. This of course indicates that all gaps between all adjacent struts and points of inflection of the stent matrix should be as constant as possible. Generally, one does not modulate the
The present invention is concerned with the above-explained problem. It seeks to improve the in situ bend capability of stents including those seen in WO 01/32102. However, the invention also seeks to achieve this performance enhancement without sacrificing other attractive qualities of stents such as disclosed in WO 01/32102. For example, simplicity of modelling of stress distributions within the stent is attractive in the management of fatigue performance of metal stents. Manufacturing simplicity of course facilitates management of cost which should improve access to stents, for those people who need them.
Looking at WO 01/32102, one can quickly see that performance in extreme bending could be enhanced by extending the length of the portions that connect adjacent zig-zag stenting rings.
The longer these "bridges" then the more the stent can bend without abutment of peaks on the inside of the bend. However, large axial gaps between adjacent stenting rings are not desirable, for then the tissue of the lumen that is being stented by the prosthesis is relatively unsupported, at least between adjacent stenting rings.
For the same reason, one seeks as far as possible to distribute the metallic material of the stent as evenly as possible over the length and circumference of the tubular envelope of the stent so that support for the stented tissue is as even and uninterrupted as possible. This of course indicates that all gaps between all adjacent struts and points of inflection of the stent matrix should be as constant as possible. Generally, one does not modulate the
4 strut matrix of a stent, over the length and circumference of the stent, to suit tissue variations within the stenting site. Generally, one does not seek to place a particular point on the circumference of the stent in opposition to a particular zone of tissue within the stenting site. For these reasons alone, one seeks a stent matrix that is everywhere the same over the length and circumference of the prosthesis.
In principle, the problem addressed in the present invention, and the solution here disclosed, is useful in all classes of stenting prostheses. That is to say, it works with a stent matrix that exhibits the (spiral) turns around the axis of a helical stent, as well as with a stent that features a stack of endless stenting rings. It works with balloon-expandable stents and resilient self-expanding stents as well as with nickel titanium shape memory alloy stents.
Summary of the invention Nevertheless, according to the present invention, it is contemplated to depart from the prior good design practice, and deliberately configure the stent matrix so that it is locally different, at one point at least, around the circumference of at least every second stenting ring within the prosthesis. In short, we envisage within each stenting ring at least one location (we call it a "stagger zone") - where the gap between adjacent points of inflection is smaller (but it could be greater) than the otherwise constant (or near constant) "wavelength" around the circumference of the prosthesis for that particular stenting ring.
It will be appreciated that, for any particular pair of adjacent stenting rings, even just one such abnormal gap (stagger zone) could be enough to set up a circumferential offset between the otherwise facing "peak-to-peak" points of inflection that we see in, for example, Fig. 4 of WO
01/32102. In practice, however, a design with only one stagger zone on the circumference might not be enough to deliver the desired circumferential offset all around the circumference, especially in designs that feature a large number of struts, in any one turn around the axis of the prosthesis. Four stagger zones are likely to be enough.
Designs with two, three or four such zones are presently preferred, but up to 6 stagger zones per turn are readily conceivable, the more so with stent design with a notably small mesh size in their matrix.
As mentioned above, it is the connectors between adjacent stenting rings that prevent adjacent stenting rings from rotating around the long axis of the prosthesis relative to each other and thereby preserve the designed intended relationship between facing stenting rings and their respective points of inflection. Generally, it will be convenient to incorporate the design variation that creates the abnormal gap between adjacent points of inflection with the design of the connector zone between two adjacent turns.
Thus, in perhaps the simplest case, we can envisage a connector from which two struts extend into a stenting ring or turn on one side of the connector, and two other struts extend in the other axial direction, into the next adjacent stenting ring or turn. If the angle between the first two struts is "normal" for that stenting ring, but the angle between the opposite pair of struts, in the other of the two stenting rings, is much smaller than "normal", then the points of inflection circumferentially on either side of the connector, that would be facing each other in the classic construction of WO 01/32102, will be circumferentially offset from each other, because of the different angle of the struts each side of the connector. Think of the connector as the trunk of a human body, with the legs of the body slightly open and the two arms of the body. Imagine the angle between the upwardly outstretched arms significantly greater than the angle between the legs.
Rather than set out a string of statements of invention, and then repeat them in a set of claims, we opt for economy of text, refrain from reciting statements of invention, and present various aspects of the above explained inventive concept in claims appended to this description.
We have stated that setting up a "peak-to-valley"
configuration of otherwise facing inflection zones is conveniently incorporated in the design of portions that connect adjacent stenting rings (or helical turns). However, one can readily envisage that the necessary offset can be created in a stagger zone that is circumferentially spaced from connectors. There is no imperative that the stagger zone must be coincident with the connector zone.
It will be evident that a stagger zone can be created in a number of different ways. One can locally manipulate the mechanical properties of the material of the stagger zone, not just be local modulation of the dimensions of the inflection points or struts within the stagger zone, relative to the rest of the circumference of the stenting ring, but could also contemplate manipulation of the mechanical properties of the material in the stagger zone by local heat treatment or even chemical treatment. It is even possible to envisage adding components to an otherwise "classic" stenting ring structure as in WO 01/32102, such as a flexible "tie"
between the two struts that are destined to deliver a smaller than usual gap between adjacent points of inflection. When a painter erects an easel, there is a "piece of string" that runs between the front frame of the easel, and the rear strut of the easel, not far above the ground, where the gap between the front legs of the easel and the single rear leg of the easel rest on the ground. A classic stent such as shown in WO 01/32102 could be modified by inclusion in it of judiciously placed "pieces of string" from biologically compatible material, in order to restrain two adjacent struts of selected stenting rings of the prosthesis from opening to the full extent that occurs for all the other struts of that particular stenting ring. (We mention this possibility not with any expectation that it will be a preferred construction, but in the recognition that competitors stimulated by the present disclosure might be obliged to turn to such constructions in the hope of avoiding the inventive concept of the present application). The motto "keep it simple" is rather powerful and the present inventors are proud of a contribution to the art that is essentially simple but should deliver a powerful enhancement of performance.
At this juncture, it is worth noting that a shape memory alloy stent is given its "remembered" configuration by a heat treatment. In the case of WO 01/32102, that heat treatment is given with the points of inflection arranged "peak-to-peak".
With shape memory alloy stents embodying the present invention, however, the heat treatment is with the inflection points arranged as intended, therefore, not peak to peak, but in the circumferentially staggered arrangement brought about by the stagger zone(s).
In the context of the present invention, attention is directed to the disclosure of US/2004/0073290 and, in particular, drawings Figures 4 and 5 and the associated text.
We see adjacent zig-zag stenting rings with points of inflection that are more or less "peak-to-peak" in the compact configuration of drawing Fig. 4, but not so much peak-to-peak in the expanded configuration of drawing Fig. 5.
However, the struts of any particular zig-zag stenting ring are not all the same length. Some are relatively long, some are relatively short, and some are of intermediate length. By contrast, it appears that the angle that opens up between any two struts that diverge from any particular point of inflection is always the same, so that any technical effect of circumferential displacement of peak-to-peak points of inflection is accomplished not by local variation of an angle between two adjacent struts but, rather, by modulations of the length of adjacent struts in each of the stenting rings.
Putting it another way, each connector portion 24 is the intersection of two straight lines in the form of an "X"
shape and this is not what is envisaged with the present invention.
Thinking about the bend capability of any particular stent design, this might be limited by peak to peak abutment on the inside of the (banana) bend but could also be restricted by incipient buckling of the stent matrix at some point on the matrix. Clearly, to obtain benefit from the present invention, the stent matrix to which it is to be applied must be capable of bending without buckling, to the extent needed to bring the benefits of the present invention into play. In general, the sparser the population of connectors, the more capacity the lattice will have to bend without buckling.
Brief description of the drawings For a better understanding of the present invention, and to show more clearly how the same may be carried into effect, reference will now be made, by way of example, to the accompanying drawings, in which:
Figs. 1 and 2 show, respectively content of Figs. 6 and 2 of US/2003/0055485, being a tubular stent structure opened out flat, seen in plan view, in respectively the radially compact and radially expanded dispositions;
Fig. 3 is a reproduction of Fig. 5 of US/2004/0073290, being a portion of a tubular stent structure, opened out flat, and in a radially expanded configuration;
Figs. 4 and 5 reproduce drawing Figs. 3 and 4 of applicant's WO 01/32102, being respectively side views of a stent structure in the radially compact and radially expanded dispositions;
Figs. 6 and 7 are corresponding views of a stent structure in accordance with the present invention; and Figs. 8 and 9 are views corresponding to those of Figs.
4 and 5, or Figs. 6 and 7, showing another embodiment of the present invention.
Detailed description Figs. 1 to 5 give only the most cursory impression of the wealth of stent strut matrix proposals contained within the state of the art. However, they provide enough disclosure to set the advantages of the present invention in the context of relevant prior art.
Looking first at Figs. 1 and 2, we see an example of a stent which utilises circumferential support structures 12 in the form of zig-zag stenting rings. These are spaced apart along the long axis of the stent. They are made up of struts 12 interspersed by points of inflection 18 which US/2003/0055485 designates "apex portions". These apex portions are mostly free to take up positions, in the expanded Fig. 2 disposition of the stent, which are governed only by the stresses transmitted through the struts of that particular stenting ring, or transmitted to that stenting ring by the bodily tissue that presses against it. However, there are also connecting struts 16 each of which joins a selected one of the apex portions of one stenting ring with a selected apex portion of an adjacent stenting ring. From Fig.
1, we see that the connecting struts have length direction that is in the circumferential direction of the stent tube, so that the opposite ends of each particular connecting strut 16 are circumferentially spaced from each other. In the radially compact disposition of Fig. 1, the circumferentially extending connecting strut 16 spans an intervening apex portion between its two ends. However, when the stent expands into its radially expanded configuration represented by Fig.
2, the circumferential length of the connecting strut 16 is not enough to span across an intervening apex portion, because the apex portions arranged around the circumference of any particular stenting ring have moved away from each other by an amount greater than the length of the connecting strut. By selecting a connecting strut length that is approximately half the distance between two adjacent apex portions of the same stenting ring, in the expanded configuration of the stent, one can achieve a "staggering" of the evenly spaced apex portions of one stenting ring, relative to the equal spacing of the apex portions of the next adjacent stenting ring that "faces" the stenting ring of the other end of the connecting strut.
In consequence, when the stent in its expanded configuration is subject to longitudinal compression, or when it is bent sharply (so that its longitudinal axis is not longer straight but arcuate) the facing apex portions on the inside of the bend, or that approach each other as the stent is longitudinally compressed do not butt up against each other but, instead, move into the free gap between two spaced apart apex portions of the other of the two facing stenting rings.
In US/2003/0055485, paragraph 0031, it is stated that the geometry of the stent in the radially compact delivery disposition of Fig. 1 is "highly flexible" so that it can tolerate axial compression on the inside of a bend as described above. Looking at Fig. 1 (Fig. 6 of the US
publication) it is not immediately evident how the stated flexibility is provided.
We turn now to Fig. 3, which corresponds to Fig. 5 of US/2004/0073290. In this case, one can see that the connector portions between adjacent zig-zag stenting rings have a very simple construction. They are remarkably short in length but, to the extent that they have a length direction, it is parallel to the longitudinal axis of the stent, rather than in a circumferential direction. Accordingly, there is no circumferential offset between the apex portions facing each other and connected by the connector strut 24.
Nevertheless, we see from Fig. 3, that there is a circumferential offset between unconnected apex portions of adjacent stenting rings.
The offset is accomplished by providing a range of different strut lengths in any particular stenting ring. In particular, each connector 24 is at the apex of a first pair of relatively long struts and a second pair of relatively short struts. Each stenting ring features struts of three different lengths, namely A) short, B) intermediate length and C) long.
And we see from Fig. 3 how the strut length progresses around the circumference of each stenting ring in a sequence ABCCBA.
We can see how the apex portions at the open end of a bifurcation between two A-struts both fall within a single gap between two C-struts of the adjacent stenting ring. This overlap occurs periodically around the circumference of the prosthesis, on each occasion midway between two adjacent connector portions 24.
In the compact disposition of the stent of Fig. 3, apex portions are "head-to-head" or "peak-to-peak" all the way around the circumference of the stenting cylinder, not just at those locations where a connector portion 24 lies between the head-to-head apex portions. In this respect, there is reduced flexibility in the compact delivery disposition of the stent device, comparable with that of the device of Fig.
1 described above. Again, it is not immediately evident how the device delivers bent flexibility in the compact delivery disposition.
The present applicant specialises in self-expanding stent devices that are formed from a tubular workpiece of nickel titanium shape memory alloy ("NITINOL" trademark). The tube is formed into a stent precursor by forming in it a multiplicity of slits (cut by a laser) that it is convenient to provide all mutually parallel to each other and to the long axis of the tubular workpiece. One such construction can be seen in Fig. 4, this corresponding to Fig. 3 of applicant's earlier publication WO 01/32102, the contents of which are hereby incorporated by reference. Reference to the WO document will reveal how, following laser cutting, portions of the tubular workpiece are removed to leave "holes" in the slitted tube, indicated by reference 60 in Fig. 4. It will be grasped by the skilled reader that provision of these voids in the slitted tube endows the tube, in its delivery system, confined by a sheath that prevents premature self-expansion, greater flexibility for the sheath to advance along a tortuous delivery path to a site of stenting in the body.
Fig. 5 shows the expanded disposition of the Fig. 4 stent construction. A pattern of zig-zag stenting rings connected by short connecting portions 62 can be readily recognised and it can also be seen that the apex portions (here in designated "points of inflection") of adjacent zig-zag stenting rings are facing each other, not only across the connected 62 but also elsewhere around the circumference of the stenting device. Thus, when the expanded stenting device of Fig. 5 is subject to severe lengthwise compressive stress, or severe bending, there is a possibility for facing points of inflection of axially adjacent zig-zag stenting rings to approach each other closely, or even touch on the inside of the bend. The problem being tackled when the present invention was made was how to reduce the likelihood of this adverse event occurring.
One embodiment of the present invention, which does succeed in setting the facing points of inflection of adjacent stenting rings circumferentially offset from each other, will now be described be reference to drawings Figures 6 and 7.
Fig. 6 shows a distribution of slits in a tubular workpiece opened out flat, and the similarity with the slit distribution of Fig 4 is immediately apparent. Note that Fig.
4 is a view from the side of the workpiece, and does not show the workpiece opened out flat whereas Fig. 6 shows the entire circumference of the tubular workpiece, laid out flat on the page. We see from Fig. 6 that there are two connecting struts 80 connecting any two adjacent stenting rings 82. We see at the left-hand end of Fig. 6 the terminal stenting ring 84 which has a longer slit length and is also evident in Fig. 4.
We note that Fig. 4 shows the entire length of the stent whereas Fig. 6 shows only a portion of the length of the stent. Whereas the connectors 80 are interspersed by voids 60 just as in Fig. 4, there are no voids between the increased length end stenting ring 84 and its next adjacent normal length stenting ring 82'. Whereas there are two connector portions 80 between the normal length stenting rings, there are 14 connectors 86 between the end stenting ring 84 and its neighbour 82'.
Noteworthy in Fig. 6 is the pattern of length of the individual slits cut by the laser. In general, the slits have a single length, but there are two exceptions. The first exception is that the slit length is longer at the end of the tubular workpiece, to form the end stenting ring 84. One such slit is marked in Fig. 6 with reference 88. The second exception is the length of the slit that terminates at one end of each connector portion 80. One such slit, of shorter length then the others, is designated in Fig. 6 with reference 90. We need to look at Fig.7 to appreciate the consequence of short struts 90.
Fig. 7 reveals two of the many connector portions 80. Each connector 80 sits between two adjacent stenting rings at the points of inflection 92 of any one stenting ring are all to be found on a notional circular locus that is transverse to the longitudinal axis of the stent. A gap "t" exists between any particular such circular loci D and E facing each other at periodical intervals down the length of the stent. Within these two circles, we find a circumferential offset between the spaced apart points of inflection 92 in circle E and those of the facing circle D. The offset is found everywhere except at the periodically spaced connectors (in this example there are four) 80.
Turning our attention to the next adjacent pair of facing circles F and G in Fig. 7, the origin of the circumferential offset can be seen in the opposing relationship of the points of inflection 92A, B, C and D. The gap between apex 92B and 92C on the stenting ring that includes circle G is the regular gap between two struts of "normal" length. However, because of the reduced slit length 90, the circumferential gap between points of inflection 92A and 92D is abnormally small so that both points of inflection 92A and 92D "fit" in the normal sized gap between apex 92B and 92C of circle G. In the terminology adopted in the present specification, the zone that includes points of inflection 92A, B, C and D is designated a stagger zone. From Fig. 7 it is immediately evident that providing such a stagger zone by using an abnormally short slit length has a disadvantage, namely, that the gap between points of inflection 92A and 92D is shorter than the regular gaps between other points of inflection spaced around circle F. It hardly need be stated that optimal use of material within a stent matrix calls for a regular matrix of struts, with a minimal amount of material in the radially compact delivery disposition, and a uniformed distribution of that material in the expanded configuration (all gaps the same size) so as to achieve a maximum ratio of expanded diameter to radially compress delivery diameter.
Deliberately accepting a plurality of unnecessarily small gaps around the circumference of each stenting ring will have an adverse effect on this ratio of diameters and is therefore not something of itself desirable to stent designers.
Nevertheless, the present invention is attractive, when taken in the context of balancing conflicting constraints on the stent designer. Looking at Fig. 6, one can see the evident simplicity of the stent strut and slit arrangement. The government regulatory authorities impose stringent quality requirements on stent manufacturers. For example, stents must meet stringent metal fatigue requirements. Finite element analysis of stent designs is of crucial importance. A design that is inherently simple should lend itself to reliable prediction of its properties in service. Being able to predict how a stent will perform after it has been installed in a human body is a significant advantage for stent manufacturers that compete to provide the stents most attractive to doctors and medical services.
Reference is now made to Figures 8 and 9. These have been annotated with references the same as are used in Figures 6 and 7, to identify corresponding features. Noteworthy is that there are four connectors rather than two, connecting adjacent stenting rings. Clearly, each stent ring comprises pairs of struts which are unconnected to any pairs of struts of an adjacent stent ring. Further is clear that a number of adjacent stent rings are spaced from each other. Fig. 8 shows the left-hand end of the stent whereas Fig. 9 shows the full length. Actually, the Fig. 9 stent is not the same as the Fig. 8 stent because Fig. 8 shows longer struts in the two end rings but Fig. 9 does not.
In Fig. 9, it is helpful to consider connectors 80A and 80B.
The former has the asymmetric shape of all the other connectors of zig-zag rings 82. The latter has an X shape because it is part of the transition from the stagger zone rings 82 to the end ring 84 that lacks any stagger zone.
Shown is that the closest end points of a pair of struts of one stent ring and a pair of struts of another stent ring are connected.
The embodiments illustrated in Figs. 6 to 9 represent only one of a multitude of ways to bring about an angle between struts that is different from the otherwise regular angle between struts around the remainder of the circumference of any particular stenting ring. For example, one could locally modify the material of the stenting ring, either in the points of inflection at one or both ends of the struts that are to form the abnormal size gap, or by judicious modification of the dimensions of those points of inflection or the two struts running between them. Above-mentioned WO 01/32102 contemplates manual removal of individual scrap portions to create voids 60. There are voids 60 in Fig. 6. If manual intervention is to be relied upon to create the voids 60 in an embodiment of the present invention, then it would not be beyond the bounds of imagination to intervene locally, and manually, at portions of the abluminal surface of the workpiece where the properties of the material are to be modified locally in order to deliver a gap of different size, or angle of different size, between two adjacent struts of any particular stenting ring. One envisages that the material could be modified in its composition, by local application of a substance to cause a chemical reaction, or by local application of a substance to modify the microstructure of the material at that point, or by local application of heat or cooling to give the material at that location a different thermal history of that of the material of the remainder of the stenting ring.
In this context, the disclosure of W02001/076508,from the present applicant, which explains how particular strut configurations can be created by using a jig to hold the workpiece in a particular desired configuration during the heat treatment which "sets" the "remembered" configuration of the struts in the shape memory alloy. Thinking along these lines, one could use instead of struts of different lengths a jig that holds the struts in a configuration such as is shown in Fig. 7, when giving the workpiece its "remembered" configuration, so that it should open up at the stenting site to the remembered disposition even if the length of slit 90 is just the same as the length of all the other slits in the stenting ring.
When thinking of workpieces of every day household dimensions, such as how to prevent a door opening too far, one would use a strut between the door and the frame that has a set length corresponding to the maximum opening that one wishes to impose on the door. In the same way, one could envisage some sort of collapsing tie to impose a maximum size on the gap between points of inflection 92A and 92D, that extends between the respective struts between the slit 90. Of course, stents are very small, but by no means as small as the nanometer dimensions that are in the minds of designers of medical devices, so there seems no justification for dismissing such tie pieces as impracticable. The reality is that, as stent designs become ever more sophisticated, so the range of applications for stents becomes ever greater and, with that, the demand for stents to mimic ever more closely the flexible behaviour of the original bodily tissue, especially when called upon, from time to time, to bend tightly along its length. The challenge is to build a stent that is strong enough to perform the stenting function which is after all the reason for its surgical implantation in the body while, at the same time, rendering the prosthesis as soft and bendy as possible in all other aspects. The present invention makes a valuable contribution to this objective.
Stents need not be made of nickel titanium alloy. Another biologically compatible material familiar to stent designers is stainless steel. Great efforts are currently being made to use other materials such as biologically compatible polymers.
All such stents can benefit from the present invention regardless how they are formed. The illustrated embodiments are not limiting.
Stents need not display the same strut matrix over their entire length. We envisage embodiments in which only part of the length of the prosthesis is given the high flexibility of the present invention. Thus, there may be some turns of the stent matrix that include stagger zones, to deliver flexibility, and other parts of the length of the stent (e.g.
end zones, or a mid-length portion) where high flexibility is contra-indicated, and so no stagger zones need be provided in these parts of the stent matrix.
In principle, the problem addressed in the present invention, and the solution here disclosed, is useful in all classes of stenting prostheses. That is to say, it works with a stent matrix that exhibits the (spiral) turns around the axis of a helical stent, as well as with a stent that features a stack of endless stenting rings. It works with balloon-expandable stents and resilient self-expanding stents as well as with nickel titanium shape memory alloy stents.
Summary of the invention Nevertheless, according to the present invention, it is contemplated to depart from the prior good design practice, and deliberately configure the stent matrix so that it is locally different, at one point at least, around the circumference of at least every second stenting ring within the prosthesis. In short, we envisage within each stenting ring at least one location (we call it a "stagger zone") - where the gap between adjacent points of inflection is smaller (but it could be greater) than the otherwise constant (or near constant) "wavelength" around the circumference of the prosthesis for that particular stenting ring.
It will be appreciated that, for any particular pair of adjacent stenting rings, even just one such abnormal gap (stagger zone) could be enough to set up a circumferential offset between the otherwise facing "peak-to-peak" points of inflection that we see in, for example, Fig. 4 of WO
01/32102. In practice, however, a design with only one stagger zone on the circumference might not be enough to deliver the desired circumferential offset all around the circumference, especially in designs that feature a large number of struts, in any one turn around the axis of the prosthesis. Four stagger zones are likely to be enough.
Designs with two, three or four such zones are presently preferred, but up to 6 stagger zones per turn are readily conceivable, the more so with stent design with a notably small mesh size in their matrix.
As mentioned above, it is the connectors between adjacent stenting rings that prevent adjacent stenting rings from rotating around the long axis of the prosthesis relative to each other and thereby preserve the designed intended relationship between facing stenting rings and their respective points of inflection. Generally, it will be convenient to incorporate the design variation that creates the abnormal gap between adjacent points of inflection with the design of the connector zone between two adjacent turns.
Thus, in perhaps the simplest case, we can envisage a connector from which two struts extend into a stenting ring or turn on one side of the connector, and two other struts extend in the other axial direction, into the next adjacent stenting ring or turn. If the angle between the first two struts is "normal" for that stenting ring, but the angle between the opposite pair of struts, in the other of the two stenting rings, is much smaller than "normal", then the points of inflection circumferentially on either side of the connector, that would be facing each other in the classic construction of WO 01/32102, will be circumferentially offset from each other, because of the different angle of the struts each side of the connector. Think of the connector as the trunk of a human body, with the legs of the body slightly open and the two arms of the body. Imagine the angle between the upwardly outstretched arms significantly greater than the angle between the legs.
Rather than set out a string of statements of invention, and then repeat them in a set of claims, we opt for economy of text, refrain from reciting statements of invention, and present various aspects of the above explained inventive concept in claims appended to this description.
We have stated that setting up a "peak-to-valley"
configuration of otherwise facing inflection zones is conveniently incorporated in the design of portions that connect adjacent stenting rings (or helical turns). However, one can readily envisage that the necessary offset can be created in a stagger zone that is circumferentially spaced from connectors. There is no imperative that the stagger zone must be coincident with the connector zone.
It will be evident that a stagger zone can be created in a number of different ways. One can locally manipulate the mechanical properties of the material of the stagger zone, not just be local modulation of the dimensions of the inflection points or struts within the stagger zone, relative to the rest of the circumference of the stenting ring, but could also contemplate manipulation of the mechanical properties of the material in the stagger zone by local heat treatment or even chemical treatment. It is even possible to envisage adding components to an otherwise "classic" stenting ring structure as in WO 01/32102, such as a flexible "tie"
between the two struts that are destined to deliver a smaller than usual gap between adjacent points of inflection. When a painter erects an easel, there is a "piece of string" that runs between the front frame of the easel, and the rear strut of the easel, not far above the ground, where the gap between the front legs of the easel and the single rear leg of the easel rest on the ground. A classic stent such as shown in WO 01/32102 could be modified by inclusion in it of judiciously placed "pieces of string" from biologically compatible material, in order to restrain two adjacent struts of selected stenting rings of the prosthesis from opening to the full extent that occurs for all the other struts of that particular stenting ring. (We mention this possibility not with any expectation that it will be a preferred construction, but in the recognition that competitors stimulated by the present disclosure might be obliged to turn to such constructions in the hope of avoiding the inventive concept of the present application). The motto "keep it simple" is rather powerful and the present inventors are proud of a contribution to the art that is essentially simple but should deliver a powerful enhancement of performance.
At this juncture, it is worth noting that a shape memory alloy stent is given its "remembered" configuration by a heat treatment. In the case of WO 01/32102, that heat treatment is given with the points of inflection arranged "peak-to-peak".
With shape memory alloy stents embodying the present invention, however, the heat treatment is with the inflection points arranged as intended, therefore, not peak to peak, but in the circumferentially staggered arrangement brought about by the stagger zone(s).
In the context of the present invention, attention is directed to the disclosure of US/2004/0073290 and, in particular, drawings Figures 4 and 5 and the associated text.
We see adjacent zig-zag stenting rings with points of inflection that are more or less "peak-to-peak" in the compact configuration of drawing Fig. 4, but not so much peak-to-peak in the expanded configuration of drawing Fig. 5.
However, the struts of any particular zig-zag stenting ring are not all the same length. Some are relatively long, some are relatively short, and some are of intermediate length. By contrast, it appears that the angle that opens up between any two struts that diverge from any particular point of inflection is always the same, so that any technical effect of circumferential displacement of peak-to-peak points of inflection is accomplished not by local variation of an angle between two adjacent struts but, rather, by modulations of the length of adjacent struts in each of the stenting rings.
Putting it another way, each connector portion 24 is the intersection of two straight lines in the form of an "X"
shape and this is not what is envisaged with the present invention.
Thinking about the bend capability of any particular stent design, this might be limited by peak to peak abutment on the inside of the (banana) bend but could also be restricted by incipient buckling of the stent matrix at some point on the matrix. Clearly, to obtain benefit from the present invention, the stent matrix to which it is to be applied must be capable of bending without buckling, to the extent needed to bring the benefits of the present invention into play. In general, the sparser the population of connectors, the more capacity the lattice will have to bend without buckling.
Brief description of the drawings For a better understanding of the present invention, and to show more clearly how the same may be carried into effect, reference will now be made, by way of example, to the accompanying drawings, in which:
Figs. 1 and 2 show, respectively content of Figs. 6 and 2 of US/2003/0055485, being a tubular stent structure opened out flat, seen in plan view, in respectively the radially compact and radially expanded dispositions;
Fig. 3 is a reproduction of Fig. 5 of US/2004/0073290, being a portion of a tubular stent structure, opened out flat, and in a radially expanded configuration;
Figs. 4 and 5 reproduce drawing Figs. 3 and 4 of applicant's WO 01/32102, being respectively side views of a stent structure in the radially compact and radially expanded dispositions;
Figs. 6 and 7 are corresponding views of a stent structure in accordance with the present invention; and Figs. 8 and 9 are views corresponding to those of Figs.
4 and 5, or Figs. 6 and 7, showing another embodiment of the present invention.
Detailed description Figs. 1 to 5 give only the most cursory impression of the wealth of stent strut matrix proposals contained within the state of the art. However, they provide enough disclosure to set the advantages of the present invention in the context of relevant prior art.
Looking first at Figs. 1 and 2, we see an example of a stent which utilises circumferential support structures 12 in the form of zig-zag stenting rings. These are spaced apart along the long axis of the stent. They are made up of struts 12 interspersed by points of inflection 18 which US/2003/0055485 designates "apex portions". These apex portions are mostly free to take up positions, in the expanded Fig. 2 disposition of the stent, which are governed only by the stresses transmitted through the struts of that particular stenting ring, or transmitted to that stenting ring by the bodily tissue that presses against it. However, there are also connecting struts 16 each of which joins a selected one of the apex portions of one stenting ring with a selected apex portion of an adjacent stenting ring. From Fig.
1, we see that the connecting struts have length direction that is in the circumferential direction of the stent tube, so that the opposite ends of each particular connecting strut 16 are circumferentially spaced from each other. In the radially compact disposition of Fig. 1, the circumferentially extending connecting strut 16 spans an intervening apex portion between its two ends. However, when the stent expands into its radially expanded configuration represented by Fig.
2, the circumferential length of the connecting strut 16 is not enough to span across an intervening apex portion, because the apex portions arranged around the circumference of any particular stenting ring have moved away from each other by an amount greater than the length of the connecting strut. By selecting a connecting strut length that is approximately half the distance between two adjacent apex portions of the same stenting ring, in the expanded configuration of the stent, one can achieve a "staggering" of the evenly spaced apex portions of one stenting ring, relative to the equal spacing of the apex portions of the next adjacent stenting ring that "faces" the stenting ring of the other end of the connecting strut.
In consequence, when the stent in its expanded configuration is subject to longitudinal compression, or when it is bent sharply (so that its longitudinal axis is not longer straight but arcuate) the facing apex portions on the inside of the bend, or that approach each other as the stent is longitudinally compressed do not butt up against each other but, instead, move into the free gap between two spaced apart apex portions of the other of the two facing stenting rings.
In US/2003/0055485, paragraph 0031, it is stated that the geometry of the stent in the radially compact delivery disposition of Fig. 1 is "highly flexible" so that it can tolerate axial compression on the inside of a bend as described above. Looking at Fig. 1 (Fig. 6 of the US
publication) it is not immediately evident how the stated flexibility is provided.
We turn now to Fig. 3, which corresponds to Fig. 5 of US/2004/0073290. In this case, one can see that the connector portions between adjacent zig-zag stenting rings have a very simple construction. They are remarkably short in length but, to the extent that they have a length direction, it is parallel to the longitudinal axis of the stent, rather than in a circumferential direction. Accordingly, there is no circumferential offset between the apex portions facing each other and connected by the connector strut 24.
Nevertheless, we see from Fig. 3, that there is a circumferential offset between unconnected apex portions of adjacent stenting rings.
The offset is accomplished by providing a range of different strut lengths in any particular stenting ring. In particular, each connector 24 is at the apex of a first pair of relatively long struts and a second pair of relatively short struts. Each stenting ring features struts of three different lengths, namely A) short, B) intermediate length and C) long.
And we see from Fig. 3 how the strut length progresses around the circumference of each stenting ring in a sequence ABCCBA.
We can see how the apex portions at the open end of a bifurcation between two A-struts both fall within a single gap between two C-struts of the adjacent stenting ring. This overlap occurs periodically around the circumference of the prosthesis, on each occasion midway between two adjacent connector portions 24.
In the compact disposition of the stent of Fig. 3, apex portions are "head-to-head" or "peak-to-peak" all the way around the circumference of the stenting cylinder, not just at those locations where a connector portion 24 lies between the head-to-head apex portions. In this respect, there is reduced flexibility in the compact delivery disposition of the stent device, comparable with that of the device of Fig.
1 described above. Again, it is not immediately evident how the device delivers bent flexibility in the compact delivery disposition.
The present applicant specialises in self-expanding stent devices that are formed from a tubular workpiece of nickel titanium shape memory alloy ("NITINOL" trademark). The tube is formed into a stent precursor by forming in it a multiplicity of slits (cut by a laser) that it is convenient to provide all mutually parallel to each other and to the long axis of the tubular workpiece. One such construction can be seen in Fig. 4, this corresponding to Fig. 3 of applicant's earlier publication WO 01/32102, the contents of which are hereby incorporated by reference. Reference to the WO document will reveal how, following laser cutting, portions of the tubular workpiece are removed to leave "holes" in the slitted tube, indicated by reference 60 in Fig. 4. It will be grasped by the skilled reader that provision of these voids in the slitted tube endows the tube, in its delivery system, confined by a sheath that prevents premature self-expansion, greater flexibility for the sheath to advance along a tortuous delivery path to a site of stenting in the body.
Fig. 5 shows the expanded disposition of the Fig. 4 stent construction. A pattern of zig-zag stenting rings connected by short connecting portions 62 can be readily recognised and it can also be seen that the apex portions (here in designated "points of inflection") of adjacent zig-zag stenting rings are facing each other, not only across the connected 62 but also elsewhere around the circumference of the stenting device. Thus, when the expanded stenting device of Fig. 5 is subject to severe lengthwise compressive stress, or severe bending, there is a possibility for facing points of inflection of axially adjacent zig-zag stenting rings to approach each other closely, or even touch on the inside of the bend. The problem being tackled when the present invention was made was how to reduce the likelihood of this adverse event occurring.
One embodiment of the present invention, which does succeed in setting the facing points of inflection of adjacent stenting rings circumferentially offset from each other, will now be described be reference to drawings Figures 6 and 7.
Fig. 6 shows a distribution of slits in a tubular workpiece opened out flat, and the similarity with the slit distribution of Fig 4 is immediately apparent. Note that Fig.
4 is a view from the side of the workpiece, and does not show the workpiece opened out flat whereas Fig. 6 shows the entire circumference of the tubular workpiece, laid out flat on the page. We see from Fig. 6 that there are two connecting struts 80 connecting any two adjacent stenting rings 82. We see at the left-hand end of Fig. 6 the terminal stenting ring 84 which has a longer slit length and is also evident in Fig. 4.
We note that Fig. 4 shows the entire length of the stent whereas Fig. 6 shows only a portion of the length of the stent. Whereas the connectors 80 are interspersed by voids 60 just as in Fig. 4, there are no voids between the increased length end stenting ring 84 and its next adjacent normal length stenting ring 82'. Whereas there are two connector portions 80 between the normal length stenting rings, there are 14 connectors 86 between the end stenting ring 84 and its neighbour 82'.
Noteworthy in Fig. 6 is the pattern of length of the individual slits cut by the laser. In general, the slits have a single length, but there are two exceptions. The first exception is that the slit length is longer at the end of the tubular workpiece, to form the end stenting ring 84. One such slit is marked in Fig. 6 with reference 88. The second exception is the length of the slit that terminates at one end of each connector portion 80. One such slit, of shorter length then the others, is designated in Fig. 6 with reference 90. We need to look at Fig.7 to appreciate the consequence of short struts 90.
Fig. 7 reveals two of the many connector portions 80. Each connector 80 sits between two adjacent stenting rings at the points of inflection 92 of any one stenting ring are all to be found on a notional circular locus that is transverse to the longitudinal axis of the stent. A gap "t" exists between any particular such circular loci D and E facing each other at periodical intervals down the length of the stent. Within these two circles, we find a circumferential offset between the spaced apart points of inflection 92 in circle E and those of the facing circle D. The offset is found everywhere except at the periodically spaced connectors (in this example there are four) 80.
Turning our attention to the next adjacent pair of facing circles F and G in Fig. 7, the origin of the circumferential offset can be seen in the opposing relationship of the points of inflection 92A, B, C and D. The gap between apex 92B and 92C on the stenting ring that includes circle G is the regular gap between two struts of "normal" length. However, because of the reduced slit length 90, the circumferential gap between points of inflection 92A and 92D is abnormally small so that both points of inflection 92A and 92D "fit" in the normal sized gap between apex 92B and 92C of circle G. In the terminology adopted in the present specification, the zone that includes points of inflection 92A, B, C and D is designated a stagger zone. From Fig. 7 it is immediately evident that providing such a stagger zone by using an abnormally short slit length has a disadvantage, namely, that the gap between points of inflection 92A and 92D is shorter than the regular gaps between other points of inflection spaced around circle F. It hardly need be stated that optimal use of material within a stent matrix calls for a regular matrix of struts, with a minimal amount of material in the radially compact delivery disposition, and a uniformed distribution of that material in the expanded configuration (all gaps the same size) so as to achieve a maximum ratio of expanded diameter to radially compress delivery diameter.
Deliberately accepting a plurality of unnecessarily small gaps around the circumference of each stenting ring will have an adverse effect on this ratio of diameters and is therefore not something of itself desirable to stent designers.
Nevertheless, the present invention is attractive, when taken in the context of balancing conflicting constraints on the stent designer. Looking at Fig. 6, one can see the evident simplicity of the stent strut and slit arrangement. The government regulatory authorities impose stringent quality requirements on stent manufacturers. For example, stents must meet stringent metal fatigue requirements. Finite element analysis of stent designs is of crucial importance. A design that is inherently simple should lend itself to reliable prediction of its properties in service. Being able to predict how a stent will perform after it has been installed in a human body is a significant advantage for stent manufacturers that compete to provide the stents most attractive to doctors and medical services.
Reference is now made to Figures 8 and 9. These have been annotated with references the same as are used in Figures 6 and 7, to identify corresponding features. Noteworthy is that there are four connectors rather than two, connecting adjacent stenting rings. Clearly, each stent ring comprises pairs of struts which are unconnected to any pairs of struts of an adjacent stent ring. Further is clear that a number of adjacent stent rings are spaced from each other. Fig. 8 shows the left-hand end of the stent whereas Fig. 9 shows the full length. Actually, the Fig. 9 stent is not the same as the Fig. 8 stent because Fig. 8 shows longer struts in the two end rings but Fig. 9 does not.
In Fig. 9, it is helpful to consider connectors 80A and 80B.
The former has the asymmetric shape of all the other connectors of zig-zag rings 82. The latter has an X shape because it is part of the transition from the stagger zone rings 82 to the end ring 84 that lacks any stagger zone.
Shown is that the closest end points of a pair of struts of one stent ring and a pair of struts of another stent ring are connected.
The embodiments illustrated in Figs. 6 to 9 represent only one of a multitude of ways to bring about an angle between struts that is different from the otherwise regular angle between struts around the remainder of the circumference of any particular stenting ring. For example, one could locally modify the material of the stenting ring, either in the points of inflection at one or both ends of the struts that are to form the abnormal size gap, or by judicious modification of the dimensions of those points of inflection or the two struts running between them. Above-mentioned WO 01/32102 contemplates manual removal of individual scrap portions to create voids 60. There are voids 60 in Fig. 6. If manual intervention is to be relied upon to create the voids 60 in an embodiment of the present invention, then it would not be beyond the bounds of imagination to intervene locally, and manually, at portions of the abluminal surface of the workpiece where the properties of the material are to be modified locally in order to deliver a gap of different size, or angle of different size, between two adjacent struts of any particular stenting ring. One envisages that the material could be modified in its composition, by local application of a substance to cause a chemical reaction, or by local application of a substance to modify the microstructure of the material at that point, or by local application of heat or cooling to give the material at that location a different thermal history of that of the material of the remainder of the stenting ring.
In this context, the disclosure of W02001/076508,from the present applicant, which explains how particular strut configurations can be created by using a jig to hold the workpiece in a particular desired configuration during the heat treatment which "sets" the "remembered" configuration of the struts in the shape memory alloy. Thinking along these lines, one could use instead of struts of different lengths a jig that holds the struts in a configuration such as is shown in Fig. 7, when giving the workpiece its "remembered" configuration, so that it should open up at the stenting site to the remembered disposition even if the length of slit 90 is just the same as the length of all the other slits in the stenting ring.
When thinking of workpieces of every day household dimensions, such as how to prevent a door opening too far, one would use a strut between the door and the frame that has a set length corresponding to the maximum opening that one wishes to impose on the door. In the same way, one could envisage some sort of collapsing tie to impose a maximum size on the gap between points of inflection 92A and 92D, that extends between the respective struts between the slit 90. Of course, stents are very small, but by no means as small as the nanometer dimensions that are in the minds of designers of medical devices, so there seems no justification for dismissing such tie pieces as impracticable. The reality is that, as stent designs become ever more sophisticated, so the range of applications for stents becomes ever greater and, with that, the demand for stents to mimic ever more closely the flexible behaviour of the original bodily tissue, especially when called upon, from time to time, to bend tightly along its length. The challenge is to build a stent that is strong enough to perform the stenting function which is after all the reason for its surgical implantation in the body while, at the same time, rendering the prosthesis as soft and bendy as possible in all other aspects. The present invention makes a valuable contribution to this objective.
Stents need not be made of nickel titanium alloy. Another biologically compatible material familiar to stent designers is stainless steel. Great efforts are currently being made to use other materials such as biologically compatible polymers.
All such stents can benefit from the present invention regardless how they are formed. The illustrated embodiments are not limiting.
Stents need not display the same strut matrix over their entire length. We envisage embodiments in which only part of the length of the prosthesis is given the high flexibility of the present invention. Thus, there may be some turns of the stent matrix that include stagger zones, to deliver flexibility, and other parts of the length of the stent (e.g.
end zones, or a mid-length portion) where high flexibility is contra-indicated, and so no stagger zones need be provided in these parts of the stent matrix.
Claims (33)
1. A tubular prosthesis with a longitudinal axis, that is radially expandable from a radially compact delivery disposition to a radially larger deployed disposition, the prosthesis exhibiting a succession of turns around the axis, which turns are helical or endless discrete loops each having an axial length direction, adjacent turns being connected by connecter portions distributed around the circumference of the prosthesis, each of the turns being made up of struts that extend the length of the turn and are interspersed by inflection zones located at the axial ends of each of the said turns such that, when the prosthesis expands radially, gaps open up between adjacent struts of each of the turns, the inflection zones being distributed regularly around the circumference so that the gaps are substantially the same size as each other around the circumference of the turn, characterised in that at least every second turn exhibits at least one stagger zone within which one of the gaps between adjacent said struts is of an individual size different from that common to the other gaps of that second turn, and wherein the stagger zone includes one of said connecter portions, and in which said one of the connector portions corresponds to the confluence of four said struts, namely a first pair of struts in a first said turn and a second pair of struts in said second turn, wherein the angle between the second pair of struts is an individual angle that is smaller than a regular angle between struts of said second turn in the deployed disposition, thereby to create said stagger zone;
whereby the inflection zones in said second turn that lie circumferentially next to the stagger zone are displaced, in accordance with the individual gap size, out of the facing relationship that obtains in the radially compact disposition of the prosthesis, with the corresponding zones of inflection in the next adjacent turn.
whereby the inflection zones in said second turn that lie circumferentially next to the stagger zone are displaced, in accordance with the individual gap size, out of the facing relationship that obtains in the radially compact disposition of the prosthesis, with the corresponding zones of inflection in the next adjacent turn.
2. The tubular prosthesis as claimed in claim 1, which is a stent.
3. The tubular prosthesis as claimed in any one of claims 1 and 2, which is a self-expanding prosthesis.
4. The tubular prosthesis as claimed in any one of claims 1, 2 and 3, which is made of nickel-titanium shape memory alloy.
5. The tubular prosthesis as claimed in any one of claims 1 to 4 wherein the struts in the stagger zone have a length different from that of the struts elsewhere in said second turn.
6. The tubular prosthesis as claimed in any one of claims 1 to 5, wherein each turn has from two to six stagger zones.
7. The tubular prosthesis as claimed in any one of claims 1 to 6, wherein material in the stagger zone is different from material elsewhere in the second turn.
8. The tubular prosthesis as claimed in claim 7, wherein the material in the stagger zone is chemically different.
9. The tubular prosthesis as claimed in claim 8, wherein the material is differently heat rated so as to exhibit a different crystalline microstructure.
10. The tubular prosthesis as claimed in claim 7, wherein the material is dimensionally different.
11. The tubular prosthesis as claimed in any one of claims 1 to 10, wherein each stagger zone modifies a size of the opposing gap between a third pair of struts of the adjacent turn to double the circumferential displacement between the inflection points of the first turn and the adjacent turn, compared with a displacement accomplished by said stagger zone gap alone.
12. The tubular prosthesis as claimed in any one of claims 1 to 11 wherein the struts are of consistent basic length, outside the stagger zones and of a different consistent non-basic length inside the stagger zones.
13. The tubular prosthesis as claimed in any one of claims 1 to 12, wherein all the zones of inflection of any one turn lie on a single circle that is transverse to the said longitudinal axis of the prosthesis, both in the compact and in the radially expanded dispositions.
14. A tubular prosthesis with a longitudinal axis, that is radially expandable from a radially compact delivery disposition to a radially larger deployed disposition, the prosthesis comprising: a succession of turns around the axis, which turns are helical or endless discrete loops each having an axial length direction, adjacent turns being connected by connector portions distributed around the circumference of the prosthesis, each of the turns being made up of struts that extend the length of the turn and are interspersed by inflection points located at the axial ends of each of the said turns such that, when the prosthesis expands radially, gaps open up between adjacent inflection points of each of the turns, wherein the gaps comprise regular gaps that are substantially the same size as each other around the circumference of the turn; at least every other of said turns exhibits at least one stagger zone gap between adjacent said inflection points, wherein a stagger zone gap is of an individual size different from that common to said regular gaps of that turn, wherein a stagger zone is formed between said inflection points forming said stagger zone gap and said inflection points of an opposing gap of an adjacent turn; one of said connector portions connects a first turn and a second turn and corresponds to the confluence of a first pair of struts in said first turn and a second pair of struts in said second turn, wherein an individual angle between said first pair of struts is smaller than an angle between said second pair of struts in the deployed disposition; whereby the inflection points in said first turn that lie circumferentially next to the stagger zone are circumferentially displaced out of facing relationship with the corresponding points of inflection in the adjacent turn.
15. The tubular prosthesis as claimed in claim 14, which is a stent.
16. The tubular prosthesis as claimed in claim 15, wherein the stent is a self-expanding stent.
17. The tubular prosthesis as claimed in claim 14, which is a self-expanding prosthesis.
18. The tubular prosthesis as claimed in claim 14, comprising a nickel-titanium shape memory alloy.
19. The tubular prosthesis as claimed in claim 14, wherein each turn has from two to six stagger zones.
20. The tubular prosthesis as claimed in claim 14, wherein the material in the stagger zone is different from the material elsewhere in the second turn.
21. The tubular prosthesis as claimed in claim 20, wherein the material is chemically different.
22. The tubular prosthesis as claimed in claim 21, wherein the material is differently heat rated so as to exhibit a different crystalline microstructure.
23. The tubular prosthesis as claimed in claim 20, wherein the material is dimensionally different.
24. The tubular prosthesis as claimed in claim 14, wherein the struts comprise regular struts forming said regular gaps and stagger zone struts forming said stagger zone gaps, said regular struts are of consistent basic length that is different from a length of said stagger zone struts.
25. The tubular prosthesis as claimed in claim 14, wherein all the points of inflection on one of said axial ends of said first turn lie on a single circle that is transverse to said longitudinal axis of the prosthesis, both in the compact delivery disposition and in the radially deployed disposition.
26. The tubular prosthesis as claimed in claim 14, wherein the struts in the stagger zone have a length different from that of the struts elsewhere in said second turn.
27. The tubular prosthesis as claimed in claim 26, wherein all the points of inflection on one axial end of any one turn lie on a single circle that is transverse to the said longitudinal axis of the prosthesis, both in the compact and in the radially expanded dispositions.
28. The tubular prosthesis as claimed in claim 27, wherein the material in the stagger zone is chemically different from the material elsewhere in the second turn.
29. The tubular prosthesis as claimed in claim 28, wherein the material is differently heat rated so as to exhibit a different crystalline microstructure.
30. The tubular prosthesis as claimed in claim 29, wherein each turn has from two to six stagger zones.
31. The tubular prosthesis as claimed in claim 30, comprising a nickel-titanium shape memory alloy.
32. The tubular prosthesis as claimed in claim 14, wherein each stagger zone modifies a size of the opposing gap between a third pair of struts of the adjacent turn to double the circumferential displacement between the inflection points of the first turn and the adjacent turn, compared with a displacement accomplished by said stagger zone gap alone.
33. The tubular prosthesis as claimed in claim 32, wherein said first pair of struts in the first turn have a length different from that of the struts elsewhere in said first turn.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0609841.2A GB0609841D0 (en) | 2006-05-17 | 2006-05-17 | Bend-capable tubular prosthesis |
| GB0609841.2 | 2006-05-17 | ||
| PCT/EP2007/004407 WO2007131798A1 (en) | 2006-05-17 | 2007-05-16 | Bend-capable tubular prosthesis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2652214A1 CA2652214A1 (en) | 2007-11-22 |
| CA2652214C true CA2652214C (en) | 2015-12-15 |
Family
ID=36660371
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2652214A Active CA2652214C (en) | 2006-05-17 | 2007-05-16 | Bend-capable tubular prosthesis |
Country Status (6)
| Country | Link |
|---|---|
| US (4) | US8403978B2 (en) |
| EP (1) | EP2020966B1 (en) |
| JP (1) | JP4827965B2 (en) |
| CA (1) | CA2652214C (en) |
| GB (1) | GB0609841D0 (en) |
| WO (1) | WO2007131798A1 (en) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0020491D0 (en) | 2000-08-18 | 2000-10-11 | Angiomed Ag | Stent with attached element and method of making such a stent |
| US6878162B2 (en) | 2002-08-30 | 2005-04-12 | Edwards Lifesciences Ag | Helical stent having improved flexibility and expandability |
| US7763067B2 (en) | 2004-09-01 | 2010-07-27 | C. R. Bard, Inc. | Stent and method for manufacturing the stent |
| CA2640234C (en) * | 2006-02-14 | 2017-01-03 | Angiomed Gmbh & Co. Medizintechnik Kg | Highly flexible stent and method of manufacture |
| GB0609841D0 (en) | 2006-05-17 | 2006-06-28 | Angiomed Ag | Bend-capable tubular prosthesis |
| GB0609911D0 (en) | 2006-05-18 | 2006-06-28 | Angiomed Ag | Bend-capable stent prosthesis |
| GB0616579D0 (en) | 2006-08-21 | 2006-09-27 | Angiomed Ag | Self-expanding stent |
| GB0616999D0 (en) | 2006-08-29 | 2006-10-04 | Angiomed Ag | Annular mesh |
| US8500793B2 (en) | 2006-09-07 | 2013-08-06 | C. R. Bard, Inc. | Helical implant having different ends |
| GB0622465D0 (en) | 2006-11-10 | 2006-12-20 | Angiomed Ag | Stent |
| GB0624419D0 (en) | 2006-12-06 | 2007-01-17 | Angiomed Ag | Stenting ring with marker |
| GB0706499D0 (en) | 2007-04-03 | 2007-05-09 | Angiomed Ag | Bendable stent |
| GB0717481D0 (en) | 2007-09-07 | 2007-10-17 | Angiomed Ag | Self-expansible stent with radiopaque markers |
| US9375327B2 (en) | 2007-12-12 | 2016-06-28 | Intact Vascular, Inc. | Endovascular implant |
| US10166127B2 (en) | 2007-12-12 | 2019-01-01 | Intact Vascular, Inc. | Endoluminal device and method |
| US7896911B2 (en) | 2007-12-12 | 2011-03-01 | Innovasc Llc | Device and method for tacking plaque to blood vessel wall |
| US9603730B2 (en) | 2007-12-12 | 2017-03-28 | Intact Vascular, Inc. | Endoluminal device and method |
| US8128677B2 (en) | 2007-12-12 | 2012-03-06 | Intact Vascular LLC | Device and method for tacking plaque to a blood vessel wall |
| US10022250B2 (en) | 2007-12-12 | 2018-07-17 | Intact Vascular, Inc. | Deployment device for placement of multiple intraluminal surgical staples |
| US9149377B2 (en) | 2008-10-10 | 2015-10-06 | Veryan Medical Ltd. | Stent suitable for deployment in a blood vessel |
| JP2012505004A (en) * | 2008-10-10 | 2012-03-01 | ヴェリヤン・メディカル・リミテッド | Stent suitable for intravascular deployment |
| US20120022578A1 (en) * | 2010-07-20 | 2012-01-26 | Cook Medical Technologies Llc | Frame-based vena cava filter |
| JP2014507196A (en) * | 2010-12-28 | 2014-03-27 | ボストン サイエンティフィック サイムド，インコーポレイテッド | Stent |
| US10390977B2 (en) | 2011-06-03 | 2019-08-27 | Intact Vascular, Inc. | Endovascular implant |
| CN107028691B (en) | 2012-01-25 | 2019-08-16 | 因特脉管有限公司 | Intracavitary unit and method |
| DE102012220129B4 (en) * | 2012-11-05 | 2022-12-15 | Optimed Medizinische Lnstrumente Gmbh | stent |
| US9566633B2 (en) * | 2012-11-15 | 2017-02-14 | Vactronix Scientific, Inc. | Stents having a hybrid pattern and methods of manufacture |
| US9180031B2 (en) * | 2013-03-15 | 2015-11-10 | Covidien Lp | Stent with varying radius between struts |
| US9259335B2 (en) | 2013-03-15 | 2016-02-16 | Covidien Lp | Stent |
| WO2014188899A1 (en) * | 2013-05-23 | 2014-11-27 | 学校法人東海大学 | Stent |
| US20150105852A1 (en) * | 2013-10-16 | 2015-04-16 | Covidien Lp | Vascular Stent |
| DE102015100932A1 (en) | 2015-01-22 | 2016-07-28 | Aesculap Ag | Stent retractor / distractor |
| US9433520B2 (en) | 2015-01-29 | 2016-09-06 | Intact Vascular, Inc. | Delivery device and method of delivery |
| US9375336B1 (en) | 2015-01-29 | 2016-06-28 | Intact Vascular, Inc. | Delivery device and method of delivery |
| WO2016210363A1 (en) * | 2015-06-24 | 2016-12-29 | Endologix, Inc. | Endoluminal prosthesis systems and methods |
| KR101810294B1 (en) | 2015-08-31 | 2018-01-25 | 롯데첨단소재(주) | Thermoplastic resin composition having paper texture and molded article produced therefrom |
| US10993824B2 (en) | 2016-01-01 | 2021-05-04 | Intact Vascular, Inc. | Delivery device and method of delivery |
| DE102016118605A1 (en) * | 2016-09-30 | 2018-04-05 | Aesculap Ag | Retractor with puzzle connection |
| US11660218B2 (en) | 2017-07-26 | 2023-05-30 | Intact Vascular, Inc. | Delivery device and method of delivery |
| WO2023178090A1 (en) * | 2022-03-15 | 2023-09-21 | Merit Medical Systems, Inc. | Non-foreshortening balloon expandable stent frame |
Family Cites Families (173)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB453944A (en) | 1935-04-10 | 1936-09-22 | John Walter Anderson | Improvements in couplings for vehicles |
| US3597578A (en) | 1967-03-16 | 1971-08-03 | Nat Res Dev | Thermal cutting apparatus and method |
| US3943324A (en) | 1970-12-14 | 1976-03-09 | Arthur D. Little, Inc. | Apparatus for forming refractory tubing |
| FR2626046A1 (en) | 1988-01-18 | 1989-07-21 | Caoutchouc Manuf Plastique | Device for joining panels or for producing conduits and its applications |
| CA1322628C (en) | 1988-10-04 | 1993-10-05 | Richard A. Schatz | Expandable intraluminal graft |
| US5091205A (en) | 1989-01-17 | 1992-02-25 | Union Carbide Chemicals & Plastics Technology Corporation | Hydrophilic lubricious coatings |
| DE9014230U1 (en) | 1990-10-13 | 1991-11-21 | Angiomed Ag, 7500 Karlsruhe, De | |
| DE4130431A1 (en) | 1991-09-13 | 1993-03-18 | Liselotte Dr Sachse | Plastics urethral prosthesis - consists of tube and reinforced with metal rings placed in tube mould or fitted within plastics layers of tube |
| US5683448A (en) | 1992-02-21 | 1997-11-04 | Boston Scientific Technology, Inc. | Intraluminal stent and graft |
| US5383926A (en) | 1992-11-23 | 1995-01-24 | Children's Medical Center Corporation | Re-expandable endoprosthesis |
| ES2166370T3 (en) | 1993-01-19 | 2002-04-16 | Schneider Usa Inc | IMPLANTABLE FILAMENT IN COMPOSITE MATERIAL. |
| DE4303181A1 (en) | 1993-02-04 | 1994-08-11 | Angiomed Ag | Implantable catheter |
| NL9300500A (en) | 1993-03-22 | 1994-10-17 | Industrial Res Bv | Expandable hollow sleeve for locally supporting and / or strengthening a body vessel, as well as a method for manufacturing it. |
| US5345057A (en) | 1993-03-25 | 1994-09-06 | Lasag Ag | Method of cutting an aperture in a device by means of a laser beam |
| ES2157977T3 (en) | 1993-07-23 | 2001-09-01 | Cook Inc | FLEXIBLE PROBE THAT HAS A CONFORMED CONFIGURATION FROM A MATERIAL SHEET. |
| US5527353A (en) | 1993-12-02 | 1996-06-18 | Meadox Medicals, Inc. | Implantable tubular prosthesis |
| US5609627A (en) | 1994-02-09 | 1997-03-11 | Boston Scientific Technology, Inc. | Method for delivering a bifurcated endoluminal prosthesis |
| JP2825452B2 (en) | 1994-04-25 | 1998-11-18 | アドヴァンスド カーディオヴァスキュラー システムズ インコーポレーテッド | Radiopak stent marker |
| JPH07315147A (en) | 1994-05-23 | 1995-12-05 | Nishikawa Rubber Co Ltd | Attachment structure for drip weather strip |
| US5636641A (en) | 1994-07-25 | 1997-06-10 | Advanced Cardiovascular Systems, Inc. | High strength member for intracorporeal use |
| IL115755A0 (en) | 1994-10-27 | 1996-01-19 | Medinol Ltd | X-ray visible stent |
| CA2163824C (en) | 1994-11-28 | 2000-06-20 | Richard J. Saunders | Method and apparatus for direct laser cutting of metal stents |
| US7204848B1 (en) | 1995-03-01 | 2007-04-17 | Boston Scientific Scimed, Inc. | Longitudinally flexible expandable stent |
| US6896696B2 (en) | 1998-11-20 | 2005-05-24 | Scimed Life Systems, Inc. | Flexible and expandable stent |
| DE69637527D1 (en) | 1995-03-01 | 2008-06-26 | Boston Scient Scimed Inc | Longitudinally flexible and expandable stent |
| US6579314B1 (en) | 1995-03-10 | 2003-06-17 | C.R. Bard, Inc. | Covered stent with encapsulated ends |
| US6451047B2 (en) | 1995-03-10 | 2002-09-17 | Impra, Inc. | Encapsulated intraluminal stent-graft and methods of making same |
| EP0734698B9 (en) | 1995-04-01 | 2006-07-05 | Variomed AG | Stent for transluminal implantation into hollow organs |
| US6602281B1 (en) * | 1995-06-05 | 2003-08-05 | Avantec Vascular Corporation | Radially expansible vessel scaffold having beams and expansion joints |
| WO1997014375A1 (en) | 1995-10-20 | 1997-04-24 | Bandula Wijay | Vascular stent |
| AU690862B2 (en) | 1995-12-04 | 1998-04-30 | Target Therapeutics, Inc. | Fibered micro vaso-occlusive devices |
| US5645532A (en) | 1996-03-04 | 1997-07-08 | Sil-Med Corporation | Radiopaque cuff peritoneal dialysis catheter |
| US6334871B1 (en) | 1996-03-13 | 2002-01-01 | Medtronic, Inc. | Radiopaque stent markers |
| US5824042A (en) | 1996-04-05 | 1998-10-20 | Medtronic, Inc. | Endoluminal prostheses having position indicating markers |
| DE19614160A1 (en) | 1996-04-10 | 1997-10-16 | Variomed Ag | Stent for transluminal implantation in hollow organs |
| US5855596A (en) | 1996-06-25 | 1999-01-05 | International Business Machines Corporation | Modular wire band stent |
| US5922020A (en) * | 1996-08-02 | 1999-07-13 | Localmed, Inc. | Tubular prosthesis having improved expansion and imaging characteristics |
| US6174329B1 (en) | 1996-08-22 | 2001-01-16 | Advanced Cardiovascular Systems, Inc. | Protective coating for a stent with intermediate radiopaque coating |
| US6099561A (en) | 1996-10-21 | 2000-08-08 | Inflow Dynamics, Inc. | Vascular and endoluminal stents with improved coatings |
| WO1998020810A1 (en) | 1996-11-12 | 1998-05-22 | Medtronic, Inc. | Flexible, radially expansible luminal prostheses |
| DE29621207U1 (en) | 1996-12-06 | 1997-01-30 | Roland Man Druckmasch | Fastening a heat sink on a printed circuit board |
| DE19653720A1 (en) | 1996-12-10 | 1998-06-18 | Biotronik Mess & Therapieg | Stent |
| IT1291001B1 (en) | 1997-01-09 | 1998-12-14 | Sorin Biomedica Cardio Spa | ANGIOPLASTIC STENT AND ITS PRODUCTION PROCESS |
| US5858556A (en) | 1997-01-21 | 1999-01-12 | Uti Corporation | Multilayer composite tubular structure and method of making |
| US5810872A (en) | 1997-03-14 | 1998-09-22 | Kanesaka; Nozomu | Flexible stent |
| US5902475A (en) | 1997-04-08 | 1999-05-11 | Interventional Technologies, Inc. | Method for manufacturing a stent |
| US5868783A (en) | 1997-04-16 | 1999-02-09 | Numed, Inc. | Intravascular stent with limited axial shrinkage |
| US6451049B2 (en) | 1998-04-29 | 2002-09-17 | Sorin Biomedica Cardio, S.P.A. | Stents for angioplasty |
| US5741327A (en) | 1997-05-06 | 1998-04-21 | Global Therapeutics, Inc. | Surgical stent featuring radiopaque markers |
| US5843175A (en) | 1997-06-13 | 1998-12-01 | Global Therapeutics, Inc. | Enhanced flexibility surgical stent |
| DE19728337A1 (en) | 1997-07-03 | 1999-01-07 | Inst Mikrotechnik Mainz Gmbh | Implantable stent |
| US5824059A (en) | 1997-08-05 | 1998-10-20 | Wijay; Bandula | Flexible stent |
| DE69838256T2 (en) | 1997-09-24 | 2008-05-15 | Med Institute, Inc., West Lafayette | RADIAL EXPANDABLE STENT |
| US6086611A (en) | 1997-09-25 | 2000-07-11 | Ave Connaught | Bifurcated stent |
| US6022374A (en) | 1997-12-16 | 2000-02-08 | Cardiovasc, Inc. | Expandable stent having radiopaque marker and method |
| US6503271B2 (en) | 1998-01-09 | 2003-01-07 | Cordis Corporation | Intravascular device with improved radiopacity |
| US6113627A (en) * | 1998-02-03 | 2000-09-05 | Jang; G. David | Tubular stent consists of horizontal expansion struts and contralaterally attached diagonal-connectors |
| US6241762B1 (en) | 1998-03-30 | 2001-06-05 | Conor Medsystems, Inc. | Expandable medical device with ductile hinges |
| FR2777771B1 (en) | 1998-04-27 | 2000-08-25 | Microval | TUBULAR AND FLEXIBLE VASCULAR ENDOPROSTHESIS |
| US6261319B1 (en) | 1998-07-08 | 2001-07-17 | Scimed Life Systems, Inc. | Stent |
| US6273909B1 (en) | 1998-10-05 | 2001-08-14 | Teramed Inc. | Endovascular graft system |
| ES2409117T3 (en) * | 1998-11-20 | 2013-06-25 | Boston Scientific Limited | Longitudinally flexible expandable stent. |
| US6355057B1 (en) | 1999-01-14 | 2002-03-12 | Medtronic, Inc. | Staggered endoluminal stent |
| AU3370400A (en) * | 1999-02-26 | 2000-09-14 | Advanced Cardiovascular Systems Inc. | Stent with customized flexibility |
| US7029492B1 (en) * | 1999-03-05 | 2006-04-18 | Terumo Kabushiki Kaisha | Implanting stent and dilating device |
| DE29904817U1 (en) | 1999-03-16 | 1999-05-27 | Amg Handelsgesellschaft Fuer A | Blood vessel support device |
| US6325825B1 (en) | 1999-04-08 | 2001-12-04 | Cordis Corporation | Stent with variable wall thickness |
| US6464723B1 (en) | 1999-04-22 | 2002-10-15 | Advanced Cardiovascular Systems, Inc. | Radiopaque stents |
| US6551351B2 (en) | 1999-07-02 | 2003-04-22 | Scimed Life Systems | Spiral wound stent |
| US6379381B1 (en) | 1999-09-03 | 2002-04-30 | Advanced Cardiovascular Systems, Inc. | Porous prosthesis and a method of depositing substances into the pores |
| US6585757B1 (en) | 1999-09-15 | 2003-07-01 | Advanced Cardiovascular Systems, Inc. | Endovascular stent with radiopaque spine |
| US6387123B1 (en) | 1999-10-13 | 2002-05-14 | Advanced Cardiovascular Systems, Inc. | Stent with radiopaque core |
| US20010047200A1 (en) * | 1999-10-13 | 2001-11-29 | Raymond Sun | Non-foreshortening intraluminal prosthesis |
| DE19952295A1 (en) | 1999-10-29 | 2001-05-23 | Angiomed Ag | Method of making a stent |
| US20040054400A1 (en) | 1999-11-12 | 2004-03-18 | Granada Vuan Fernando | Conformable vascular stent |
| US6471721B1 (en) | 1999-12-30 | 2002-10-29 | Advanced Cardiovascular Systems, Inc. | Vascular stent having increased radiopacity and method for making same |
| GB0003387D0 (en) | 2000-02-14 | 2000-04-05 | Angiomed Ag | Stent matrix |
| GB0009030D0 (en) | 2000-04-12 | 2000-05-31 | Angiomed Ag | Self-expanding metal stent and method of making it |
| US20030114918A1 (en) | 2000-04-28 | 2003-06-19 | Garrison Michi E. | Stent graft assembly and method |
| WO2001089421A2 (en) | 2000-05-22 | 2001-11-29 | Orbus Medical Technologies Inc. | Self-expanding stent |
| DE10026307A1 (en) | 2000-05-26 | 2001-11-29 | Variomed Ag Balzers | Stent, positioning element and insertion catheter |
| GB0020491D0 (en) | 2000-08-18 | 2000-10-11 | Angiomed Ag | Stent with attached element and method of making such a stent |
| US20020072792A1 (en) | 2000-09-22 | 2002-06-13 | Robert Burgermeister | Stent with optimal strength and radiopacity characteristics |
| US20070276476A1 (en) | 2000-09-29 | 2007-11-29 | Llanos Gerard H | Medical Devices, Drug Coatings and Methods for Maintaining the Drug Coatings Thereon |
| US6547818B1 (en) | 2000-10-20 | 2003-04-15 | Endotex Interventional Systems, Inc. | Selectively thinned coiled-sheet stents and methods for making them |
| US6758859B1 (en) | 2000-10-30 | 2004-07-06 | Kenny L. Dang | Increased drug-loading and reduced stress drug delivery device |
| WO2002049544A1 (en) | 2000-12-19 | 2002-06-27 | Vascular Architects, Inc. | Biologically active agent delivery apparatus and method |
| US6565599B1 (en) | 2000-12-28 | 2003-05-20 | Advanced Cardiovascular Systems, Inc. | Hybrid stent |
| US6540777B2 (en) | 2001-02-15 | 2003-04-01 | Scimed Life Systems, Inc. | Locking stent |
| US6623518B2 (en) | 2001-02-26 | 2003-09-23 | Ev3 Peripheral, Inc. | Implant delivery system with interlock |
| US20020138136A1 (en) | 2001-03-23 | 2002-09-26 | Scimed Life Systems, Inc. | Medical device having radio-opacification and barrier layers |
| DE60209583T2 (en) | 2001-03-30 | 2006-12-21 | Terumo K.K. | stent |
| US6629994B2 (en) | 2001-06-11 | 2003-10-07 | Advanced Cardiovascular Systems, Inc. | Intravascular stent |
| US8197535B2 (en) | 2001-06-19 | 2012-06-12 | Cordis Corporation | Low profile improved radiopacity intraluminal medical device |
| US20020198589A1 (en) | 2001-06-22 | 2002-12-26 | Leong Veronica Jade | Tessellated stent and method of manufacture |
| US6605110B2 (en) | 2001-06-29 | 2003-08-12 | Advanced Cardiovascular Systems, Inc. | Stent with enhanced bendability and flexibility |
| US6979346B1 (en) | 2001-08-08 | 2005-12-27 | Advanced Cardiovascular Systems, Inc. | System and method for improved stent retention |
| IL160817A0 (en) * | 2001-09-10 | 2004-08-31 | Medinol Ltd | Longitudinally flexible stent |
| US20030055485A1 (en) | 2001-09-17 | 2003-03-20 | Intra Therapeutics, Inc. | Stent with offset cell geometry |
| WO2003055414A1 (en) | 2001-10-18 | 2003-07-10 | Advanced Stent Technologies, Inc. | Stent for vessel support, coverage and side branch accessibility |
| US20050182477A1 (en) | 2001-12-20 | 2005-08-18 | White Geoffrey H. | Intraluminal stent and graft |
| DE10201151B4 (en) | 2002-01-15 | 2007-10-04 | Qualimed Innovative Medizinprodukte Gmbh | Stent with marker |
| US7354450B2 (en) | 2002-01-30 | 2008-04-08 | Boston Scientific Scimed, Inc. | Stent with wishbone connectors and serpentine bands |
| GB0206061D0 (en) | 2002-03-14 | 2002-04-24 | Angiomed Ag | Metal structure compatible with MRI imaging, and method of manufacturing such a structure |
| US7691461B1 (en) | 2002-04-01 | 2010-04-06 | Advanced Cardiovascular Systems, Inc. | Hybrid stent and method of making |
| US7637935B2 (en) | 2002-05-06 | 2009-12-29 | Abbott Laboratories | Endoprosthesis for controlled contraction and expansion |
| EP2529707B1 (en) * | 2002-05-08 | 2015-04-15 | Abbott Laboratories | Endoprosthesis having foot extensions |
| US7195648B2 (en) | 2002-05-16 | 2007-03-27 | Cordis Neurovascular, Inc. | Intravascular stent device |
| US20030225448A1 (en) | 2002-05-28 | 2003-12-04 | Scimed Life Systems, Inc. | Polar radiopaque marker for stent |
| US20040015229A1 (en) | 2002-07-22 | 2004-01-22 | Syntheon, Llc | Vascular stent with radiopaque markers |
| US6969402B2 (en) | 2002-07-26 | 2005-11-29 | Syntheon, Llc | Helical stent having flexible transition zone |
| AU2003254132A1 (en) * | 2002-08-30 | 2004-03-19 | Advanced Cardiovascular Systems, Inc. | Stent with nested rings |
| US6878162B2 (en) | 2002-08-30 | 2005-04-12 | Edwards Lifesciences Ag | Helical stent having improved flexibility and expandability |
| US7135038B1 (en) | 2002-09-30 | 2006-11-14 | Advanced Cardiovascular Systems, Inc. | Drug eluting stent |
| US7223283B2 (en) * | 2002-10-09 | 2007-05-29 | Boston Scientific Scimed, Inc. | Stent with improved flexibility |
| US7331986B2 (en) | 2002-10-09 | 2008-02-19 | Boston Scientific Scimed, Inc. | Intraluminal medical device having improved visibility |
| DE60336158D1 (en) | 2002-10-11 | 2011-04-07 | Univ Connecticut | ON SEMICRISTALLINE THERMOPLASTIC POLYURETHANES BASED FOR NANOSTRUCTURED HARD SEGMENTS BASED FORM MEMORY PILARMERS |
| US8105373B2 (en) | 2002-12-16 | 2012-01-31 | Boston Scientific Scimed, Inc. | Flexible stent with improved axial strength |
| ES2392712T3 (en) | 2002-12-17 | 2012-12-13 | Fluor Corporation | Procedure for the removal of acid gas and pollutants with near zero emission |
| US20050033410A1 (en) | 2002-12-24 | 2005-02-10 | Novostent Corporation | Vascular prothesis having flexible configuration |
| US7771463B2 (en) | 2003-03-26 | 2010-08-10 | Ton Dai T | Twist-down implant delivery technologies |
| US6846323B2 (en) | 2003-05-15 | 2005-01-25 | Advanced Cardiovascular Systems, Inc. | Intravascular stent |
| US20040236409A1 (en) | 2003-05-20 | 2004-11-25 | Pelton Alan R. | Radiopacity intraluminal medical device |
| ES2364555T3 (en) | 2003-05-23 | 2011-09-06 | Boston Scientific Limited | CANNULAS WITH INCORPORATED LOOP TERMINATIONS. |
| DE10325678A1 (en) | 2003-06-02 | 2004-12-23 | Biotronik Meß- und Therapiegeräte GmbH & Co. Ingenieurbüro Berlin | Connection system for connecting a stent to a radio-opaque marker and method for establishing a connection between a stent and two or more radio-opaque markers |
| US20040254637A1 (en) | 2003-06-16 | 2004-12-16 | Endotex Interventional Systems, Inc. | Sleeve stent marker |
| US7479157B2 (en) | 2003-08-07 | 2009-01-20 | Boston Scientific Scimed, Inc. | Stent designs which enable the visibility of the inside of the stent during MRI |
| US20050060025A1 (en) | 2003-09-12 | 2005-03-17 | Mackiewicz David A. | Radiopaque markers for medical devices |
| US7175654B2 (en) | 2003-10-16 | 2007-02-13 | Cordis Corporation | Stent design having stent segments which uncouple upon deployment |
| US20050149168A1 (en) | 2003-12-30 | 2005-07-07 | Daniel Gregorich | Stent to be deployed on a bend |
| US7021893B2 (en) | 2004-01-09 | 2006-04-04 | United Technologies Corporation | Fanned trailing edge teardrop array |
| GB0400571D0 (en) | 2004-01-12 | 2004-02-11 | Angiomed Gmbh & Co | Implant |
| ATE455520T1 (en) | 2004-01-27 | 2010-02-15 | Med Inst Inc | BARB FOR ATTACHING TO A MEDICAL PROSTHESIS |
| US7243408B2 (en) | 2004-02-09 | 2007-07-17 | Boston Scientific Scimed, Inc. | Process method for attaching radio opaque markers to shape memory stent |
| TW200528463A (en) | 2004-02-19 | 2005-09-01 | Chung Shan Inst Of Science | A method for preparing an bifunctional arylphosphonite antioxidant |
| US8034096B2 (en) | 2004-03-31 | 2011-10-11 | Cook Medical Technologies Llc | Stent-graft with graft to graft attachment |
| EP1744705B8 (en) | 2004-05-05 | 2009-10-07 | Invatec S.p.A | Endoluminal prosthesis |
| US20050278017A1 (en) | 2004-06-09 | 2005-12-15 | Scimed Life Systems, Inc. | Overlapped stents for scaffolding, flexibility and MRI compatibility |
| CN1993155B (en) | 2004-06-25 | 2011-05-11 | 日本瑞翁株式会社 | Dilator |
| US7763066B2 (en) | 2004-07-28 | 2010-07-27 | Cook Incorporated | Stent with an end member having a lateral extension |
| GB0417078D0 (en) | 2004-07-30 | 2004-09-01 | Angiomed Ag | Flexible implant |
| GB0417077D0 (en) | 2004-07-30 | 2004-09-01 | Angiomed Ag | Medical implant such as a stent |
| US20060060266A1 (en) | 2004-09-01 | 2006-03-23 | Pst, Llc | Stent and method for manufacturing the stent |
| DE102004043166A1 (en) | 2004-09-03 | 2006-03-09 | Carl Baasel Lasertechnik Gmbh & Co. Kg | Intravascular stent and method for its production |
| US20060054604A1 (en) | 2004-09-10 | 2006-03-16 | Saunders Richard J | Laser process to produce drug delivery channel in metal stents |
| DE202004014789U1 (en) | 2004-09-22 | 2005-01-27 | Campus Medizin & Technik Gmbh | Stent for implantation into or onto a hollow organ comprises a cutout serving as receptacle for a conical marker element which is X-ray opaque and is oriented radially relative to the stent axis |
| DE102004045994A1 (en) | 2004-09-22 | 2006-03-30 | Campus Gmbh & Co. Kg | Stent for implantation in or around a hollow organ with marker elements made from a radiopaque material |
| WO2006036912A2 (en) | 2004-09-27 | 2006-04-06 | Echobio Llc | Systems, apparatus and methods related to helical, non-helical or removable stents with rectilinear ends |
| US20060085065A1 (en) | 2004-10-15 | 2006-04-20 | Krause Arthur A | Stent with auxiliary treatment structure |
| FR2879131B1 (en) | 2004-12-14 | 2010-12-17 | Saint Gobain | COMPLEX GLAZING CONSISTS OF AT LEAST TWO CONTIGUOUS GLASS ELEMENTS AND METHOD FOR PRODUCING THE COMPLEX GLAZING. |
| US20060216431A1 (en) | 2005-03-28 | 2006-09-28 | Kerrigan Cameron K | Electrostatic abluminal coating of a stent crimped on a balloon catheter |
| ES2340864T3 (en) | 2005-03-30 | 2010-06-10 | Terumo Kabushiki Kaisha | CANULA |
| US7854760B2 (en) | 2005-05-16 | 2010-12-21 | Boston Scientific Scimed, Inc. | Medical devices including metallic films |
| US20060265049A1 (en) | 2005-05-19 | 2006-11-23 | Gray Robert W | Stent and MR imaging process and device |
| US20070112421A1 (en) | 2005-11-14 | 2007-05-17 | O'brien Barry | Medical device with a grooved surface |
| US7381217B2 (en) | 2005-12-23 | 2008-06-03 | Boston Scientific Scimed, Inc. | Serpentine stent pattern |
| GB0609841D0 (en) | 2006-05-17 | 2006-06-28 | Angiomed Ag | Bend-capable tubular prosthesis |
| GB0609911D0 (en) | 2006-05-18 | 2006-06-28 | Angiomed Ag | Bend-capable stent prosthesis |
| GB0613670D0 (en) | 2006-07-10 | 2006-08-16 | Angiomed Ag | Tubular metal prosthesis and method of making it |
| GB0616579D0 (en) | 2006-08-21 | 2006-09-27 | Angiomed Ag | Self-expanding stent |
| GB0616729D0 (en) | 2006-08-23 | 2006-10-04 | Angiomed Ag | Method of welding a component to a shape memory alloy workpiece |
| GB0616999D0 (en) | 2006-08-29 | 2006-10-04 | Angiomed Ag | Annular mesh |
| US8500793B2 (en) | 2006-09-07 | 2013-08-06 | C. R. Bard, Inc. | Helical implant having different ends |
| FR2907587B1 (en) | 2006-10-23 | 2008-12-26 | Commissariat Energie Atomique | MAGNETIC DEVICE WITH PERPENDICULAR ANIMATION AND INTERCOUNTING COMPENSATORY INTERCONNECTIVE LAYER. |
| GB0622465D0 (en) | 2006-11-10 | 2006-12-20 | Angiomed Ag | Stent |
| GB0624419D0 (en) | 2006-12-06 | 2007-01-17 | Angiomed Ag | Stenting ring with marker |
| GB0703379D0 (en) | 2007-02-21 | 2007-03-28 | Angiomed Ag | Stent with radiopaque marker |
| GB0706499D0 (en) | 2007-04-03 | 2007-05-09 | Angiomed Ag | Bendable stent |
| GB0717481D0 (en) | 2007-09-07 | 2007-10-17 | Angiomed Ag | Self-expansible stent with radiopaque markers |
| US20090204203A1 (en) | 2008-02-07 | 2009-08-13 | Medtronic Vascular, Inc. | Bioabsorbable Stent Having a Radiopaque Marker |
| JP5806289B2 (en) | 2010-04-06 | 2015-11-10 | ボストン サイエンティフィック サイムド，インコーポレイテッドＢｏｓｔｏｎ Ｓｃｉｅｎｔｉｆｉｃ Ｓｃｉｍｅｄ，Ｉｎｃ． | Endoprosthesis |
| US8888841B2 (en) | 2010-06-21 | 2014-11-18 | Zorion Medical, Inc. | Bioabsorbable implants |
| US8992761B2 (en) | 2012-07-13 | 2015-03-31 | Abbott Cardiovascular Systems, Inc. | Methods for passivating metallic implantable medical devices including radiopaque markers |
-
2006
- 2006-05-17 GB GBGB0609841.2A patent/GB0609841D0/en not_active Ceased
-
2007
- 2007-05-16 EP EP07725322A patent/EP2020966B1/en active Active
- 2007-05-16 CA CA2652214A patent/CA2652214C/en active Active
- 2007-05-16 JP JP2009510356A patent/JP4827965B2/en active Active
- 2007-05-16 WO PCT/EP2007/004407 patent/WO2007131798A1/en active Application Filing
- 2007-05-16 US US12/300,985 patent/US8403978B2/en active Active
-
2013
- 2013-03-22 US US13/849,312 patent/US9155642B2/en active Active
-
2015
- 2015-10-12 US US14/881,043 patent/US9956098B2/en active Active
-
2018
- 2018-04-30 US US15/966,120 patent/US10849770B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20160030213A1 (en) | 2016-02-04 |
| US20130218260A1 (en) | 2013-08-22 |
| CA2652214A1 (en) | 2007-11-22 |
| EP2020966B1 (en) | 2012-02-22 |
| US8403978B2 (en) | 2013-03-26 |
| US9956098B2 (en) | 2018-05-01 |
| US20180271684A1 (en) | 2018-09-27 |
| US10849770B2 (en) | 2020-12-01 |
| JP2009537192A (en) | 2009-10-29 |
| JP4827965B2 (en) | 2011-11-30 |
| WO2007131798A1 (en) | 2007-11-22 |
| US20100298921A1 (en) | 2010-11-25 |
| EP2020966A1 (en) | 2009-02-11 |
| US9155642B2 (en) | 2015-10-13 |
| GB0609841D0 (en) | 2006-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10849770B2 (en) | Bend-capable tubular prosthesis | |
| US10231854B2 (en) | Bend-capable stent prosthesis | |
| JP6431866B2 (en) | Hybrid stent | |
| JP2010527641A (en) | Hybrid stent having a backbone made of fiber or wire | |
| EP1223891A1 (en) | Method of making a stent | |
| WO2001076508A2 (en) | Self-expanding memory metal stent and method of making it | |
| EP2088963B1 (en) | Bifurcation stent design with over expansion capability | |
| GB2499211A (en) | Bioabsorbable stent assembly and implantable device | |
| DE202009012562U1 (en) | Stent with stretching elements | |
| CA2761759C (en) | Stent | |
| EP2178472B1 (en) | Radially expansible stent | |
| JP6373831B2 (en) | Stent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |